FDA Adverse Event Malfunction Summary report: N

EPOC BLOOD ANALYSIS SYSTEM

MDR report key: 21873997 · Received April 21, 2025

Report

Report Number
3002637618-2025-00028
Event Type
Malfunction
Date Received
April 21, 2025
Date of Event
March 15, 2025
Report Date
April 21, 2025
Manufacturer
EPOCAL INC.
Product Code
CHL
UDI-DI
00809708016685
PMA / PMN Number
K200107
Removal / Correction Number
3002637618-03-19-2025-00
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

SIEMENS HEALTHCARE DIAGNOSTICS INC. HAS CONFIRMED THE OCCURRENCE OF DISCREPANT HIGH PH RESULTS IN SAMPLES INTRODUCED WITH HIGHER INJECTION VOLUMES (BEYOND THE EPOC READER BEEP OR AFTER THE "ANALYZING SAMPLE" MESSAGE IS DISPLAYED) WITH EPOC SENSOR CONFIGURATION 45.N (SOFTWARE VERSION: EPOC HOST V3.41.2 AND EPOC NXS V4.14.9 & 4.14.11). IT SHOULD BE NOTED THAT TOTAL CARBON DIOXIDE (TCO2) IS A MEASURED VALUE THAT USES THE PH RESULT AND THAT DISCREPANT HIGH PH RESULTS MAY AFFECT THE FOLLOWING CALCULATED VALUES: ANION GAP (AGAP) (THROUGH CHCO3 OR TCO2), BASE EXCESS (BLOOD) (BE (B)), BASE EXCESS (EXTRA CELLULAR FLUID) (BE (ECF)), CALCULATED BICARBONATE (CHCO3-), CALCULATED OXYGEN SATURATION (CSO2), CALCULATED TOTAL CARBON DIOXIDE (CTCO2). SIEMENS HEALTHCARE DIAGNOSTICS DETERMINED THE ROOT CAUSE OF THE PH BIAS TO BE CAUSED BY SENSOR CONFIGURATION 45.N. SIEMENS HAS RELEASED A NOTIFICATION "DISCREPANT HIGH PH RESULTS WITH SENSOR CONFIGURATION 45.N" TO INFORM CUSTOMERS OF THE ISSUE AND PROVIDE A WORKAROUND OPTION. CRR#: 3002637618-03-19-2025-001-C.

Description of Event or Problem · 0

THE CUSTOMER REPORTED DISCREPANT HIGH PH RESULTS WHEN COMPARED TO REPEAT TESTING ON A COMPARATIVE INSTRUMENT. THERE IS NO REPORT OF INJURY DUE TO THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1517410 EPOC BLOOD ANALYSIS SYSTEM EPOC READER CHL EPOCAL INC. 00809708016685

Patients

Seq Age Sex Outcome Treatment
1 20 YR Female